---
title: "Pivotal trial of AltaValve TMVR system commences in USA and Europe"
date: "2024-10-12T10:01:37.000Z"
publishedDate: "12 octobre 2024"
summary: "4C Medical Technologies has commenced enrolment in the ATLAS trial in Europe and USA, a pivotal trial designed to assess the safety and efficacy performance of its AltaValve system. The trial will enroll patients with moderate-to-severe or severe mitral regurgitation (MR) who are unsuitable for surgery or transcatheter edge-to-edge repair (TEER)."
importance: ""
sourceUrl: "https://cardiovascularnews.com/pivotal-trial-of-altavalve-tmvr-system-commences-in-usa-and-europe/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-10-12-pivotal-trial-of-altavalve-tmvr-system-commences-in-usa-and-europe"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/4C_Medical_Technologies_Inc_picture_1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pivotal-trial-of-altavalve-tmvr-system-commences-in-usa-and-europe/"
---

![Pivotal trial of AltaValve TMVR system commences in USA and Europe](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/05/4C_Medical_Technologies_Inc_picture_1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/pivotal-trial-of-altavalve-tmvr-system-commences-in-usa-and-europe/*

## L’essentiel

4C Medical Technologies has commenced enrolment in the ATLAS trial in Europe and USA, a pivotal trial designed to assess the safety and efficacy performance of its AltaValve system. The trial will enroll patients with moderate-to-severe or severe mitral regurgitation (MR) who are unsuitable for surgery or transcatheter edge-to-edge repair (TEER).

## Lien source

https://cardiovascularnews.com/pivotal-trial-of-altavalve-tmvr-system-commences-in-usa-and-europe/
